Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...
Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...
Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
By 2030, pharmaceutical companies are expected to lose over $236 billion in revenue due to the impending ‘patent c...
Malaysia is facing a growing environmental and public health threat due to improper disposal of pharmaceutical wast...
South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
GE HealthCare (GEHC), a leading global healthcare solutions provider, has announced that Yihao Zhang, president and Chie...
ZEISS Medical Technology has announced that the National Medical Products Administration (NMPA) in China has a...
Florricks Lifecare, a leading research-driven pharmaceutical company in India, involved in R&D, production, and sale...
US-based Sunflower Therapeutics has announced its first distribution agreement with PharmNXT Biotech, an ...
Olympus Corporation of Asia Pacific (APAC) has announced a milestone for its iTind device with expanded availability acr...
Novo Nordisk, a global leader in diabetes and obesity care, reported a stellar performance for the fourth quarter (Q4) a...
“We made good progress in 2024, which was capped by a fourth quarter of strong topline growth driven by key produc...
"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance glob...
